LBA18 Pembrolizumab or placebo plus chemotherapy followed by pembrolizumab or placebo for early-stage TNBC: Updated EFS results from the phase III KEYNOTE-522 study

Peter Schmid, Javier Cortés, Rebecca Dent, Lajos Pusztai, Heather L. McArthur, Sherko Kümmel, Carsten Denkert, Y.H. Park, Rina Hui, N. Harbeck, M. Takahashi, Theodoros Foukakis, M.A. Mouret Reynier, M.I.R. Ferreira, S-A. Im, Fátima Cardoso, Yu Ding, W. Pan, Konstantinos Tryfonidis, Joyce O’Shaughnessy